- ChineseInvestors.com
is a fintech company
- It
provides financial information for Chinese-speaking investors
- The
company is in the process of spinning off its cannabidiol (CBD) division
ChineseInvestors.com, Inc. (OTCQB: CIIX) is a fintech
company that concentrates on providing financial information and services. Its
focus is on operating the foremost financial information website for
Chinese-speaking investors. The company provides real-time market commentary,
analysis and education-related services via www.ChineseFN.com.
ChineseInvestors.com has corporate offices in San Gabriel, California; New
York, New York; and Shanghai, China.
Furthermore, the company has recognized opportunities in the
U.S. cannabis industry. It has worked to take advantage of the increasing
demand for cannabidiol-based nutrition and health products. However, its
intention is to focus back on its original mission of providing financial
information and services to the greater Chinese community in the United States
and internationally. As a result, ChineseInvestors.com is progressing on its
initiative to spin off its CBD division, ChineseHempOil.com, Inc.
On January 31, 2017, the company formally launched the
website for subsidiary ChineseCBDoil.com. This portal is the world’s first CBD
health products online store in the Chinese language. The website offers an
array of nutritional supplements containing CBD. Products include purified CBD
oil; concentrated CBD; CBD extract liquid; CBD balm; CBD food; and CBD drinks.
These offerings are targeted at Chinese-speaking customers around the world.
Warren Wang, ChineseInvestors.com’s chief executive officer,
is hopeful that the spinoff of the company’s CBD subsidiary,
ChineseHempOil.com, Inc., will be completed by the end of 2018. In a news
release, Wang stated, “We intend to continue to expand our consumer division by
dedicating more resources to marketing hemp-based CBD products both
domestically and in China. At the same time, we will continue to offer our core
financial subscription services with a focus on increasing subscription
revenues through targeted marketing of the company’s new cryptocurrency
subscription services and educational products.”
The drive to legalize hemp is gaining traction. Forbes
reported recently that the U.S. Senate voted to legalize hemp after a
decades-long ban under marijuana prohibition (http://ibn.fm/B1LUZ). Therefore, to meet the growing
demand, ChineseHempOil.com is planning to expand its operations to more U.S.
States, as well as Canada and Asian markets (http://ibn.fm/fZ0iH).
ChineseInvestors.com’s CBD division is an attractive asset.
For fiscal year 2018, the company reported a 41 percent year-over-year increase
in revenues. It ascribes most of the growth to consumer product sales via its
wholly owned subsidiaries, ChineseHempOil.com Inc. and CBD Biotechnology Co.,
Ltd.
Nonetheless, the company, upon completion of its CBD assets
spin off, will return to its foundation in consulting, brand building and
education for the Chinese-speaking community. While strategically centering on
CBD hemp sales, it also has plans to create a cryptocurrency ATM network and a
domestic online coin-to-coin exchange for Chinese cryptocurrency
investors (http://ibn.fm/X94xT).
ChineseInvestors.com continually seeks new growth channels to build its
business and shareholder value.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
